Where does biopharma go from here?

End­points is field­ing the next Bio­phar­ma Sen­ti­ment In­dex (BP­SI) — a con­cise, three-minute sur­vey that dis­tills thou­sands of in­dus­try views in­to a clear quar­ter­ly bench­mark. This year is piv­otal for bio­phar­ma, and we need your per­spec­tive on where things are go­ing.

Take the sur­vey here.

The BP­SI is one of the most di­rect snap­shots of how peo­ple in­side bio­phar­ma view the road ahead. More than 1,000 in­dus­try in­sid­ers took part in the BP­SI last quar­ter. Your in­put helps keep the bench­mark rep­re­sen­ta­tive and rel­e­vant, and shapes the in­dus­try’s think­ing.

Re­spons­es are anony­mous, and par­tic­i­pants will be first to re­ceive a com­pli­men­ta­ry copy of the re­port.

Thanks for tak­ing part.